CHRONIC GVHD

Clinical trials for CHRONIC GVHD explained in plain language.

Never miss a new study

Get alerted when new CHRONIC GVHD trials appear

Sign up with your email to follow new studies for CHRONIC GVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 4 Completed 1 Terminated 1

New approach aims to tame transplant rejection without steroids

Disease control Completed

This study tested whether the drug ibrutinib could be used as the first treatment for people newly diagnosed with chronic graft-versus-host disease (cGVHD), a serious complication where donor cells attack the body after a stem cell transplant. The goal was to see if starting with…

Matched conditions: CHRONIC GVHD

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

CHRONIC GVHD

Get alerted when new CHRONIC GVHD trials appear

New approach aims to tame transplant rejection without steroids